| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1210/JCEM.86.8.7782 |
| P698 | PubMed publication ID | 11502765 |
| P2093 | author name string | Ho SM | |
| Taplin ME | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate cancer | Q181257 |
| P304 | page(s) | 3467-3477 | |
| P577 | publication date | 2001-08-01 | |
| P1433 | published in | The Journal of Clinical Endocrinology and Metabolism | Q3186902 |
| P1476 | title | Clinical review 134: The endocrinology of prostate cancer | |
| P478 | volume | 86 |
| Q39107457 | Activation of polyamine catabolic enzymes involved in diverse responses against epibrassinolide-induced apoptosis in LNCaP and DU145 prostate cancer cell lines |
| Q80498601 | Age-related histopathological lesions in the Mongolian gerbil ventral prostate as a good model for studies of spontaneous hormone-related disorders |
| Q35031739 | Background to and management of treatment-related bone loss in prostate cancer. |
| Q51067963 | Differential expression of AP-1 transcription factors in human prostate LNCaP and PC-3 cells: role of Fra-1 in transition to CRPC status. |
| Q41532348 | Down-regulation of DcR2 sensitizes androgen-dependent prostate cancer LNCaP cells to TRAIL-induced apoptosis |
| Q91632940 | Effect of Vitamin D Supplementation in Prostate Cancer: A Systematic Review of Randomized Control Trials |
| Q44185330 | Effects of an oral androgen on muscle and metabolism in older, community-dwelling men. |
| Q46974163 | Effects of voluntary wheel running on cardiac function and myosin heavy chain in chemically gonadectomized rats. |
| Q38957285 | Epibrassinolide-induced apoptosis regardless of p53 expression via activating polyamine catabolic machinery, a common target for androgen sensitive and insensitive prostate cancer cells |
| Q35196710 | Estrogens and prostate cancer: etiology, mediators, prevention, and management. |
| Q42020822 | Evaluation of oxidative stress and DNA damage in benign prostatic hyperplasia patients and comparison with controls |
| Q44060322 | Expression of prostate-specific antigen is transcriptionally regulated by genistein in prostate cancer cells |
| Q36409841 | Gene expression profiling identifies lobe-specific and common disruptions of multiple gene networks in testosterone-supported, 17beta-estradiol- or diethylstilbestrol-induced prostate dysplasia in Noble rats |
| Q53223173 | Gestational and lactational exposition to Di-N-butyl-phthalate (DBP) increases inflammation and preneoplastic lesions in prostate of wistar rats after carcinogenic N-methyl-N-nitrosourea (MNU) plus testosterone protocol. |
| Q35081520 | ICI 182,780-regulated gene expression in DU145 prostate cancer cells is mediated by estrogen receptor-beta/NFkappaB crosstalk. |
| Q41639827 | Long-term efficacy and tolerability of abdominal once-yearly histrelin acetate subcutaneous implants in patients with advanced prostate cancer. |
| Q93102856 | Loss of Fibroblast-Dependent Androgen Receptor Activation in Prostate Cancer Cells is Involved in the Mechanism of Acquired Resistance to Castration |
| Q38983706 | Metabolic syndrome in sub-Saharan Africa: "smaller twin" of a region's prostatic diseases? |
| Q45327318 | Molecular mechanisms involving prostate cancer racial disparity |
| Q37641588 | Overcoming chemoresistance in prostate cancer with Chinese medicine Tripterygium wilfordii via multiple mechanisms |
| Q40601236 | PMP24, a gene identified by MSRF, undergoes DNA hypermethylation-associated gene silencing during cancer progression in an LNCaP model |
| Q34054729 | PSA Decrease with Fulvestrant Acetate in a Hormone-Resistant Metastatic Prostate Cancer Patient: A Case Report |
| Q35053929 | Prostate carcinoma: defining therapeutic objectives and improving overall outcomes |
| Q44401618 | Reduced circulating androgen bioactivity in patients with prostate cancer |
| Q38626744 | Resistance to cancer treatment: the role of somatic genetic events and the challenges for targeted therapies |
| Q42540165 | Serum Testosterone, 17β-Estradiol and PSA Levels in Subjects with Prostate Disorders. |
| Q33295021 | Sex hormones induce direct epithelial and inflammation-mediated oxidative/nitrosative stress that favors prostatic carcinogenesis in the noble rat. |
| Q45239243 | Synthesis and in vitro characterization of ionone-based chalcones as novel antiandrogens effective against multiple clinically relevant androgen receptor mutants |
| Q39074709 | Synthesis and in vitro characterization of ionone-based compounds as dual inhibitors of the androgen receptor and NF-κB. |
| Q39290649 | Systemic treatment of metastatic prostate cancer |
| Q38055220 | Tanshinone derivatives: a patent review (January 2006 - September 2012). |
| Q33770742 | The Activity of SN33638, an Inhibitor of AKR1C3, on Testosterone and 17β-Estradiol Production and Function in Castration-Resistant Prostate Cancer and ER-Positive Breast Cancer |
| Q34189517 | The impact of point mutations in the human androgen receptor: classification of mutations on the basis of transcriptional activity |
| Q43114709 | Tissue changes in senescent gerbil prostate after hormone deprivation leads to acquisition of androgen insensitivity |
| Q34298801 | Treatment of testosterone-induced gynecomastia with the aromatase inhibitor, anastrozole |
| Q30882835 | Treatment with oxandrolone and the durability of effects in older men. |
Search more.